1Schlant RC, Forman S, Stamler J, et al. The natural history of coronary heart disease : prognostic factors after recovery from myocardial infarction in 2789 men.The 52year findings of the coronary drug project[J].Circulation, 1982,66:4012 - 414.
2Siess W. Athero-and thrombogenic actions of lysophosphati- dic acid and sphingosine-1-phosphate[J]. Biochim Biophys Acta,2002,1582:204.
3Siess W, Zangl KJ, EsslerM, et al. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions[J],Pine Natl Acad Sci USA,1999,96:6931.
4MoolenaarWH. Development of our current understanding ofbioactive lysophospholipids[J]. A nn N Y A cad Sci ,2000,905(4): 1.
5Qu XF,Song Y,Li JJ,et al.The relationship between the levels of lysophosphatidic acid and left ventricular remodeling after acute myocardial infarction [J]. Zhonghua Yi Xue Za Zhi(中文版),2004,84(12):1005.
6F ranz2Jo set N eumannMD,Ilka O ttMD,M einrad GawazMD,et al.Cardiac release of cytok ines and inflammato ry responses in a2 cute myocardial infarction[J].Circulation,1995,92(4) :748.
